- Home
- SVA vs CGC Comparison
SVA vs CGC Comparison
Compare SVA & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- CGC
- Stock Information
- Founded
- SVA N/A
- CGC N/A
- Country
- SVA
- CGC Canada
- Employees
- SVA 3261
- CGC N/A
- Industry
- SVA
- CGC Pharmaceuticals and Biotechnology
- Sector
- SVA
- CGC Health Care
- Exchange
- SVA NYSE
- CGC Nasdaq
- Market Cap
- SVA N/A
- CGC 244.5M
- IPO Year
- SVA N/A
- CGC N/A
- Fundamental
- Price
- SVA $6.47
- CGC $1.25
- Analyst Decision
- SVA
- CGC Sell
- Analyst Count
- SVA 0
- CGC 2
- Target Price
- SVA N/A
- CGC $2.00
- AVG Volume (30 Days)
- SVA N/A
- CGC 8.4M
- Earning Date
- SVA N/A
- CGC 08-08-2025
- Dividend Yield
- SVA N/A
- CGC N/A
- EPS Growth
- SVA N/A
- CGC N/A
- EPS
- SVA N/A
- CGC N/A
- Revenue
- SVA N/A
- CGC $187,146,485.00
- Revenue This Year
- SVA N/A
- CGC $11.99
- Revenue Next Year
- SVA N/A
- CGC $6.84
- P/E Ratio
- SVA N/A
- CGC N/A
- Revenue Growth
- SVA N/A
- CGC N/A
- 52 Week Low
- SVA N/A
- CGC $0.77
- 52 Week High
- SVA N/A
- CGC $8.65
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- CGC 46.21
- Support Level
- SVA N/A
- CGC $1.18
- Resistance Level
- SVA N/A
- CGC $1.34
- Average True Range (ATR)
- SVA 0.00
- CGC 0.07
- MACD
- SVA 0.00
- CGC 0.00
- Stochastic Oscillator
- SVA 0.00
- CGC 54.55
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.